Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review
Yu, Yang, Yu, Min, Li, Yanying, Zhou, Xiaojuan, Tian, Tian, Du, Yijia, Tu, Zegui, Huang, Meijuan
Published in Frontiers in oncology (19.08.2022)
Published in Frontiers in oncology (19.08.2022)
Get full text
Journal Article
Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
Luo, Jieyan, Hu, Qipeng, Gou, Maling, Liu, Xiaoke, Qin, Yi, Zhu, Jiao, Cai, Chengzhi, Tian, Tian, Tu, Zegui, Du, Yijia, Deng, Hongxin
Published in Frontiers in oncology (01.10.2021)
Published in Frontiers in oncology (01.10.2021)
Get full text
Journal Article
A risk classification system predicting the cancer-specific survival for postoperative stage IB non-small-cell lung cancer patients without lymphovascular and visceral pleural invasion
Tu, Zegui, Li, Caili, Tian, Tian, Chen, Qian
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2021)
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2021)
Get full text
Journal Article
Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer
Tu, Zegui, Chen, Xiancheng, Tian, Tian, Chen, Guo, Huang, Meijuan
Published in Aging (Albany, NY.) (26.02.2021)
Published in Aging (Albany, NY.) (26.02.2021)
Get full text
Journal Article
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer
Wang, Laduona, Wu, Yijun, Kang, Kai, Zhang, Xuanwei, Luo, Ren, Tu, Zegui, Zheng, Yue, Lin, Guo, Wang, Hui, Tang, Min, Yu, Min, Zou, Bingwen, Tong, Ruizhan, Yi, Linglu, Xue, Jianxin, Yao, Zhuoran, Lu, You
Published in Translational lung cancer research (31.05.2024)
Published in Translational lung cancer research (31.05.2024)
Get full text
Journal Article
Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review
Yu, Yang, Yu, Min, Li, Yanying, Zhou, Xiaojuan, Tian, Tian, Du, Yijia, Tu, Zegui, Huang, Meijuan
Published in Frontiers in oncology (01.01.2022)
Published in Frontiers in oncology (01.01.2022)
Get full text
Report